Citius Pharmaceuticals, Inc. — Director's Dealing 2018

Sep 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2018-09-04

Reporting Person: Dutia Suren G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-04	Options to Purchase Common Stock	$1.62	A	15000	Acquired	2028-09-04	Common Stock (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$3.45	2027-09-13	Common Stock (10000)	10000	Direct
Options to Purchase Common Stock	$8.10	2025-10-01	Common Stock (26667)	26667	Direct

Footnotes

F1: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F2: The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.

F3: The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.